- Trials with a EudraCT protocol (113)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
113 result(s) found for: Fertilization.
Displaying page 1 of 6.
EudraCT Number: 2005-000993-29 | Sponsor Protocol Number: 04I/HMG10 | Start Date*: 2005-07-19 | |||||||||||
Sponsor Name:IBSA | |||||||||||||
Full Title: A prospective, randomized, investigator-blind, controlled, clinical study of phase III on the clinical efficacy and tolerability of hMG-IBSA IBSA Institut Biochimique sa versus Menopur Ferring ... | |||||||||||||
Medical condition: COH Controlled Ovarian Hyperstimulation in ART Assisted Reproductive Technology /IVF | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004233-27 | Sponsor Protocol Number: RF-2013-02358757 | Start Date*: 2016-06-23 | |||||||||||
Sponsor Name:FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO | |||||||||||||
Full Title: Vitamin D Supplementation on Assisted Reproduction Technology (ART) outcomes: a randomized clinical controlled trial and an investigation of the involved biological mechanisms | |||||||||||||
Medical condition: in vitro fertilization | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002385-31 | Sponsor Protocol Number: 2015/582 | Start Date*: 2017-08-28 | |||||||||||
Sponsor Name:Professor Peter Humaidan, The Fertility Clinic Skive | |||||||||||||
Full Title: A double-blind, placebo-controlled multicenter trial on the effect of clindamycin and a live biotherapeutic on the reproductive outcomes of IVF patients with abnormal vaginal microbiota | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006595-11 | Sponsor Protocol Number: 07EU/Prg06 | Start Date*: 2008-09-25 | |||||||||||
Sponsor Name:IBSA Institut Biochimique SA | |||||||||||||
Full Title: Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) versus Vaginal Progesterone Gel (Crinone) for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF). | |||||||||||||
Medical condition: Patient undergoing in-Vitro Fertilization (IVF) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002993-29 | Sponsor Protocol Number: M13-625 | Start Date*: 2015-07-15 | |||||||||||
Sponsor Name:Abbott Laboratories GmbH | |||||||||||||
Full Title: A Randomized, Open-label, Two-arm, Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg daily versus Crinone 8% intravaginal progesterone gel 90 mg daily ... | |||||||||||||
Medical condition: Treatment for the luteal support in in-vitro fertilization (IVF). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021021-13 | Sponsor Protocol Number: 10EU/HMG02 | Start Date*: 2010-11-25 | |||||||||||
Sponsor Name:IBSA, Institut Biochimique S.A. | |||||||||||||
Full Title: Safety and efficacy study comparing a new hMG formulation (hMG-IBSA) to a reference product (Menopur®) in patients undergoing ovarian stimulation for in vitro fertilisation (IVF). | |||||||||||||
Medical condition: Patients, with basal FSH <10 IU/L and E2 <80 pg/ml (~290 pmol/l), undergoing controlled ovarian stimulation for in vitro fertilisation. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) DK (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004824-39 | Sponsor Protocol Number: 1 | Start Date*: 2015-09-18 | |||||||||||
Sponsor Name:UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST | |||||||||||||
Full Title: The use of GnRH antagonist versus co-flare protocol for women with low ovarian reserve undergoing first cycle of in vitro fertilization | |||||||||||||
Medical condition: response to ovarian stimulation in women with reduced ovarian reserve undergoing first cycle of in vitro fertilisaion. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004460-31 | Sponsor Protocol Number: PRINT | Start Date*: 2007-02-21 | |||||||||||
Sponsor Name:Guy's & St Thomas' NHS Foundation Trust | |||||||||||||
Full Title: A randomised controlled trial comparing the gonadotrophin releasing hormone (GnRH) agonist long regimen versus the GnRH agonist short regimen versus the GnRH antagonist regimen in poor responders u... | |||||||||||||
Medical condition: Poor ovarian response in women undergoing In vitro Fertilisation (IVF) treatment. | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017854-11 | Sponsor Protocol Number: FIBHGM-ECNC004-2010(FEBRES-09) | Start Date*: 2010-06-22 | ||||||||||||||||
Sponsor Name:Fundación para la Investigación Biomédica del Hospital Gregorio Marañón | ||||||||||||||||||
Full Title: Efecto de la dosis de FSH recombinante en el resultado de la estimulación ovárica para fecundación in vitro en pacientes con baja reserva ovárica. Estudio aleatorizado y abierto de no inferioridad.... | ||||||||||||||||||
Medical condition: Hiperestimulación ovárica controlada para inducir el desarrollo de folículos múltiples en programas de reproducción asistida | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020559-29 | Sponsor Protocol Number: IVF-03-01-052 | Start Date*: 2010-09-23 | ||||||||||||||||
Sponsor Name:Pantec Biosolutions AG | ||||||||||||||||||
Full Title: Proof of concept study to investigate the efficacy, safety and tolerability as well as the pharmacokinetics and pharmacodynamics of a newly developed patch containing follicle-stimulating hormone a... | ||||||||||||||||||
Medical condition: Healthy female oocyte donors of normal body weight (body mass index within 18 to 29 kg/m2), age from 20 to 30 years (inclusive), ultrasound of ovaries, normal endocrine status, non-smoker | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: CZ (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003938-41 | Sponsor Protocol Number: IMP 28364 | Start Date*: 2007-09-25 | |||||||||||
Sponsor Name:Merck Lipha Santé SAS | |||||||||||||
Full Title: Open label pilot study on gene expression profiling of the endometrial tissue in patients undergoing Assisted Reproductive Technology (ART: only IVF) with GONAL-f. | |||||||||||||
Medical condition: This study will be conducted in infertile women justifying ART (Assisted Reproductive Technology) treatment (only IVF - In Vitro Fecondation) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002267-18 | Sponsor Protocol Number: APTE | Start Date*: 2017-11-27 | ||||||||||||||||||||||||||
Sponsor Name:Sara Rafael Fernández | ||||||||||||||||||||||||||||
Full Title: EFFICACY AND SAFETY OF THE CONCENTRATE OF AUTOMOTIVE RICH PLASMA IN GROWTH FACTORS IN THE TREATMENT OF THE FINE ENDOMETRY IN PATIENTS SUBMITTED TO TRANSFER OF CRIO-PRESERVED EMBRYOS: CLINICAL TRIAL... | ||||||||||||||||||||||||||||
Medical condition: infertile women | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003484-56 | Sponsor Protocol Number: BOLDOS-18 | Start Date*: 2019-12-26 | |||||||||||
Sponsor Name:Miguel Caballero Campo | |||||||||||||
Full Title: Efficacy of corifolitropin alfa in double ovarian stimulation compared with two conventional ovarian stimulation cycles for embryo accmulation in low responder patients. Multicenter randomized cont... | |||||||||||||
Medical condition: Infertility in patients requiring in vitro fertilization treatment with poor ovarian response profile, defined by Bologna Criteria. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001342-18 | Sponsor Protocol Number: IB-0319-001 | Start Date*: 2019-08-19 |
Sponsor Name:Instituto Bernabeu | ||
Full Title: CONVENTIONAL STIMULATION IN FOLICULAR PHASE VS. STIMULATION IN LUTEA PHASE IN PATIENTS WITH SUBOPTIMA RESPONSE. RANDOMIZED CLINICAL TRIAL. SUBLUTEAL STUDY | ||
Medical condition: Suboptimal response of ovarian stimulation | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-003177-32 | Sponsor Protocol Number: IBMR31 | Start Date*: 2022-11-17 |
Sponsor Name:Instituto Bernabeu | ||
Full Title: Continuous ovarian stimulation in DUOSTIM cycles. | ||
Medical condition: Patients with predictive indicators of low ovarian response and who undergo double ovarian stimulation (DUOSTIM). | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002040-24 | Sponsor Protocol Number: FI028.DEX001.2019 | Start Date*: 2020-04-14 |
Sponsor Name:Dextra fertility clinic
[...]
1. Dextra fertility clinic
2. Annika Tulenheimo-Silfvast |
||
Full Title: Iron defiency as an ignored cause of infertility | ||
Medical condition: Infertility | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FI (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000420-40 | Sponsor Protocol Number: 310442 | Start Date*: 2007-08-08 | |||||||||||
Sponsor Name:Bayer Schering Pharma Oy | |||||||||||||
Full Title: Multi-center, open-label, randomized study to assess the safety and contraceptive efficacy of two doses (in vitro 12 µg/24 h and 16 µg/24 h) of the ultra low dose levonorgestrel contraceptive intra... | |||||||||||||
Medical condition: Contraception | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FI (Completed) SE (Completed) HU (Completed) FR (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000394-30 | Sponsor Protocol Number: 309988 | Start Date*: 2006-08-31 | |||||||||||
Sponsor Name:Schering Oy | |||||||||||||
Full Title: Multicenter study to investigate the bleeding profile and the insertion easiness in women inserted with a second consecutive MIRENA for contraception or menorrhagia | |||||||||||||
Medical condition: Contraception or menorrhagia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IE (Completed) FI (Completed) SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002291-42 | Sponsor Protocol Number: 308901 | Start Date*: 2005-03-17 | |||||||||||
Sponsor Name:Schering AG | |||||||||||||
Full Title: Multi-center, open, randomized, dose finding phase II study to investigate for a maximum of three years ultra low dose levonorgestrel contraceptive intrauterine systems (LCS) releasing in vitro 12 ... | |||||||||||||
Medical condition: Contraception | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FI (Completed) SE (Completed) HU (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021787-15 | Sponsor Protocol Number: CF111/301 | Start Date*: 2011-03-23 | |||||||||||
Sponsor Name:Laboratorios León Farma S.A. | |||||||||||||
Full Title: A Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety and Tolerability of Drospirenone as LF111 During 13 Cycles | |||||||||||||
Medical condition: Oral hormonal contraceptive for women without uncontrolled current diseases between 18-45 years. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) CZ (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
